Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2020
The Hi's and Lo's of Cytarabine in Acute Myeloid Leukemia
Justin M Watts, Terrence Bradley
Blood Reviews
|
August 10, 2014
Acute promyelocytic leukemia: what is the new standard of care?
Justin M Watts, Martin S Tallman
Current Hematologic Malignancy Reports
|
September 30, 2018
Leveraging Hypomethylating Agents for Better MDS Therapy
Terrence J Bradley, Justin M Watts, Ronan T Swords
Current Treatment Options in Oncology
|
October 15, 2024
Looking Beyond the Surface: Olutasidenib and Ivosidenib for Treatment of mIDH1 Acute Myeloid Leukemia
Justin M Watts, Simon J Shaw, Brian A Jonas
Cancers
|
November 3, 2020
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
Michele Stanchina, Deborah Soong, Binbin Zheng-Lin, et al.
Cancers
|
January 1, 2020
A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Fatih M Uckun, Christopher R Cogle, Tara L Lin, et al.
International Journal of Molecular Sciences
|
July 12, 2017
A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy
Justin M Watts, Aymee Perez, Lutecia Pereira, et al.
Leukemia & Lymphoma
|
November 30, 2013
Acute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literature
Elizabeth H Cull, Justin M Watts, Martin S Tallman, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Balancing Activation and Repression: CoREST-p300 Antagonism Controls Retinoic Acid-Driven Differentiation in AML
Mina M Tayari, Helena Gomes Dos Santos, Sadat Dokaneheifard, et al.
Advances in Therapy
|
February 28, 2026
Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid Leukemia
Justin M Watts, Eunice S Wang, Brian A Jonas, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2020
The Hi's and Lo's of Cytarabine in Acute Myeloid Leukemia
Justin M Watts, Terrence Bradley
Blood Reviews
|
August 10, 2014
Acute promyelocytic leukemia: what is the new standard of care?
Justin M Watts, Martin S Tallman
Current Hematologic Malignancy Reports
|
September 30, 2018
Leveraging Hypomethylating Agents for Better MDS Therapy
Terrence J Bradley, Justin M Watts, Ronan T Swords
Current Treatment Options in Oncology
|
October 15, 2024
Looking Beyond the Surface: Olutasidenib and Ivosidenib for Treatment of mIDH1 Acute Myeloid Leukemia
Justin M Watts, Simon J Shaw, Brian A Jonas
Cancers
|
November 3, 2020
Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development
Michele Stanchina, Deborah Soong, Binbin Zheng-Lin, et al.
Cancers
|
January 1, 2020
A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Fatih M Uckun, Christopher R Cogle, Tara L Lin, et al.
International Journal of Molecular Sciences
|
July 12, 2017
A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy
Justin M Watts, Aymee Perez, Lutecia Pereira, et al.
Leukemia & Lymphoma
|
November 30, 2013
Acute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literature
Elizabeth H Cull, Justin M Watts, Martin S Tallman, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Balancing Activation and Repression: CoREST-p300 Antagonism Controls Retinoic Acid-Driven Differentiation in AML
Mina M Tayari, Helena Gomes Dos Santos, Sadat Dokaneheifard, et al.
Advances in Therapy
|
February 28, 2026
Matching-Adjusted Indirect Comparison of Olutasidenib and Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Relapsed/Refractory Acute Myeloid Leukemia
Justin M Watts, Eunice S Wang, Brian A Jonas, et al.
Page
of 4